DEUTSCHE BANK AG\

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$5,281,553	704,207	+160,876	+30%	$7.50	Q4 2025
30 Sep 2025	0%	+0%	$4,721,546	543,331	+316,392	+139%	$8.69	Q3 2025
30 Jun 2025	0%	-0%	$841,944	226,939	-9,218	-3.9%	$3.71	Q2 2025
31 Mar 2025	0%	-0%	$762,787	236,157	-5,696		$3.23	Q1 2025
31 Dec 2024	0%	-0%	$1,347,122	241,853	-560,784		$5.57	Q4 2024
30 Sep 2024	0%	+0%	$8,676,506	802,637	+678,298	+500%	$10.81	Q3 2024
30 Jun 2024	0%	+0%	$2,609,876	124,339	+2,479		$20.99	Q2 2024
31 Mar 2024	0%	-0.01%	$3,882,459	121,860	-365,133		$31.86	Q1 2024
31 Dec 2023	0.01%	+0%	$9,866,478	486,993	+471,424	+3028%	$20.26	Q4 2023
30 Sep 2023	0%	-0.01%	$198,193	15,569	-660,584	-98%	$12.73	Q3 2023
30 Jun 2023	0.01%	+0.01%	$12,218,084	676,153	+595,886	+742%	$18.07	Q2 2023
31 Mar 2023	0%	+0%	$1,379,790	80,267	+5,298	+7.1%	$17.19	Q1 2023
31 Dec 2022	0%	+0%	$1,665,061	74,969	+1,649	+2.2%	$22.21	Q4 2022
30 Sep 2022	0%	+0%	$589,000	73,320	+60,027	+452%	$8.03	Q3 2022
30 Jun 2022	0%	-0%	$93,000	13,293	-2,226	-14%	$7.00	Q2 2022
31 Mar 2022	0%	-0%	$235,000	15,519	-1,764	-10%	$15.14	Q1 2022
31 Dec 2021	0%	+0%	$379,000	17,283	+422	+2.5%	$21.93	Q4 2021
30 Sep 2021	0%	+0%	$454,000	16,861	+6,220	+58%	$26.93	Q3 2021
30 Jun 2021	0%	+0%	$257,000	10,641	+930	+9.6%	$24.15	Q2 2021
31 Mar 2021	0%	+0%	$422,000	9,711	+9,711	NEW	$43.46	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.